Microchip Biotechnologies

Paired Ends

Premium

Debi Frost, Stan Lapidus

Paired Ends

Premium

Karen Nelson, Bob Strausberg, Howard Goldstein, Sidney Stolz, Andrew Last

The company plans to use the funding to commercialize its Apollo 100 system, a sample-preparation system for Sanger sequencing, and to develop the Apollo platform for the next-generation sequencing markets as well as for DNA-based human identification and forensics.

Paired Ends

Premium

Eric Green, Chung-Fan Chiou, Hubert Renauld, Jim Blair, Bill Byun

People in the News

Gladstone Institutes name Bruce Spaulding as chief of planning strategy; Bruker's Dirk Laukien resigns as William Knight and Brian Monahan promoted; plus more.

MBI plans to use the series B venture funding to develop its Apollo sample prep technologies.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.